RXR-PPARGAMMA AGONIST/GROWTH FACTOR INHIBITOR COMBINATION THERAPY FOR INDUCING APOPTOSIS AND THE TREATMENT OF CANCER

摘要

The present invention relates to novel anti-cancer treatments and compositions using combinations of at least one agonist of the RXR-PPARγ heterodimer complex selected in the group consisting of a RXRα agonist, a RXRβ agonist, a RXRγ agonist, a PPARγ agonist or a RXR-PPARγ heterodimer agonist and a growth factor inhibitor.